ROTHSCHILD & CO ASSET MANAGEMENT US INC. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROTHSCHILD & CO ASSET MANAGEMENT US INC. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2018$6,940,000
-84.2%
142,133
-65.6%
0.08%
-84.6%
Q1 2018$43,901,000
+17.2%
413,147
-34.1%
0.49%
+23.5%
Q4 2017$37,461,000
+32.0%
627,279
-46.9%
0.40%
+26.6%
Q3 2017$28,378,000
+28.9%
1,182,422
+5.0%
0.31%
+25.8%
Q2 2017$22,008,000
-14.9%
1,125,750
+2.2%
0.25%
-16.2%
Q1 2017$25,851,000
+95.4%
1,101,445
+2.1%
0.30%
+76.2%
Q4 2016$13,233,000
+2525.6%
1,078,454
+3578.1%
0.17%
+1766.7%
Q3 2016$504,000
+23.8%
29,321
+2.5%
0.01%
+28.6%
Q2 2016$407,00028,5960.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2018
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders